In the guinea pig hippocampus, K,-opioid binding sites were primarily localized in the molecular layer of the dentate gyrus as shown by autoradiography using either the K,-SekCtiVe radioligand 3H-U69,593 or the nonselective radioligand 3H-diprenorphine in the presence of unlabeled p-and b-blocking ligands. In this region, the electrophysiological effects of K,-receptor activation were identified using extracellular and intracellular recordings of dentate granule cell responses. As seen with U69,593, dynorphin B, an endogenous opioid peptide that is present in the dentate gyrus, also inhibited the population spike response.
A-and &selective opioid agonists had no effect on the amplitude of the maximally evoked response. Intracellular recordings of dentate granule cells showed no direct effects of U69,593 on the granule cells themselves. However, analysis of synaptic potentials revealed that U69,593 significantly reduced the amplitude of glutaminergic EPSPs evoked by afferent stimulation without affecting IPSP amplitudes.
The specific effect of U69,593 application on granule cell EPSPs indicates that presynaptic K,-receptor activation inhibits glutamate release from perforant path terminals in the molecular layer of the dentate gyrus. These results suggest that endogenous dynorphins present in the granule cells may act as feedback inhibitors of the major excitatory input to the dentate gyrus.
Prodynorphin-derived opioid peptides and opioid receptors have been shown to be present in specific neuronal pathways within the hippocampus (Gall et al., 1981; McGinty et al., 1983; McLean et al., 1987) and are likely to act as neurotransmitters in this region . The potential role of the endogenous dynorphin system in regulating hippocampal func-tions such as learning processes and in the regulation of neuronal excitability has been suggested by direct effects of applied peptide (McDaniel et al., 1990) by increases in dynorphin peptide levels in aged-impaired animals (Jiang et al., 1989) , and by alterations in dynorphin peptide levels following changes in the physiologic activity of hippocampal neurons (Gall, 1988; Houser et al., 1990 ) yet how endogenous dynorphins exert their effects in the hippocampus is unclear in spite of extensive electrophysiological study. In the CA1 and CA3 regions of the hippocampus, the dynorphins either had no effect (Caudle and Chawkin, 1990 ) acted via p-receptors at high concentrations of peptide (Chavkin et al., 1985) or had naloxone-insensitive effects (Walker et al., 1982; Moises and Walker, 1985; Iwama et al., 1987) . Results from pharmacologic assays in other tissues suggest that dynorphins are likely to act through K-type opioid receptors (Chavkin et al., 1982; Corbett et al., 1982) . Consistent with these findings, dynorphin A was found to have a K-IXCCptOrmediated effect in the dentate gyrus of the rat hippocampus . The absence of potent, naloxone-sensitive effects of dynorphin in the CA1 and CA3 regions may have resulted from a lack of high-affinity K-receptors in those areas.
Recent characterization has distinguished two subtypes of K-binding sites, the U69,593-sensitive (K,) and the U69,593-insensitive (Kz) sites (Zukin et al., 1988; Neck et al., 1988a Neck et al., , 1990 . In the rat brain, the majority of the K-binding sites are  whereas in the guinea pig, K,-sites predominate (Zukin et al., 1988) . As the affinity ofdynorphins for the K,-subtype has been shown to be much higher than their affinity for the K,-subtype (Neck et al., 1990) , it would seem likely that the K,-subtype would be a target for endogenous dynorphin actions. In a previous study, we determined that within the guinea pig hippocampal formation, K,-binding sites are present exclusively in the molecular layer of the dentate gyrus. Importantly, using a neurochemical assay of dynorphin release in hippocampal slices, we showed that endogenously released dynorphins could compete for binding at the K,-binding sites in the molecular layer of the dentate gyrus (Wagner et al., 1991) . These results support the hypothesis that endogenous dynorphins act at K,-receptors in the dentate gyrus; however, the physiological consequences of K,-ECeptOr activation in this region have not yet been established.
In this report, we describe the effects of K-opioids in the dentate gyrus of the guinea pig hippocampus. In contrast to the excitatory effect that opioids typically have on principal cell responses in the hippocampus (Zieglgansberger et al., 1979 ) K1-selective opioids had an inhibitory effect on dentate granule cell excitability. The results suggest that K,-reCeptOrS are located on perforant path terminals and act to inhibit excitatory amino acid release. Thus, a potential role for endogenous dynorphins in this region is to regulate the level of excitatory input carried by the perforant path into the hippocampus.
Materials and Methods
Autoradiography. Freshly dissected guinea pig hippocampi were quickly frozen in liquid Freon and cryostat sectioned (20 pm) in the transverse plane. Sections were thaw-mounted onto gelatin-coated glass slides, refrozen, and stored at -20°C overnight to allow section adherence to slides. Slides were then hydrated in 50 mM Tris (pH 7.4) for 60 min and then incubated in 50 mM Tris containing either 3 nM 'H-U69593 or 3 nM 3H-diprenorphine for 90 min at room temperature. The slides were washed twice for 1 min in ice-cold Tris, rinsed briefly in ice-cold distilled water! and dried under a stream of cold air. The sections were exposed to tntmm-sensitive film (LKB Ultrofilm) for 10 weeks. Radioligand binding to nonopioid sites (nonspecific binding) was determined in the presence of 10 PM naloxone. The selective opioid ligands [D-Pen*, L-Pens]-enkephalin (DPLPE, 1 PM) and Tyr-to-Ala-Gly-(NMe)Phe-glyol (DAMGO; 1 PM) were used to block 6-and FL-opioid binding sites, respectively (Handa et al., 1981; Mosberg et al., 1983) . U69,593 (1 PM; Lahti et al.. 1985) was used to block 3H-diprenornhine binding to K,-opioid sites. Images from the sections were-digitized, and background was subtracted using MCID software (Ramm et al., 1985) .
Membrane binding assays. Guinea pig hippocampal membranes (2% w/v), in Krebs-bicarbonate buffer [composition (mM): NaCl(l24), KC1
(4.9), KH,PO, (1.2), MgCl, (2.4), CaCl, (2.5), glucose (lo), NaHCO, (25.6)] with 10 mM HEPES added (pH 7.4), were incubated for 90 min at 23°C with 3H-U69.593 (3 nM). Increasine concentrations ofunlabeled competitor were added as indicated to generate competition curves. Membrane-bound radioligand was separated by filtration using GF/C filters (Whatman) presoaked in 0.1% polyethylenimine (Sigma), which were washed by vacuum three times with 4 ml ice-cold buffer. Bound )H-U69,593 was quantified by liquid scintillation counting [Ecolite (+), ICN]; all determinations were performed in triplicate. ICso values (the competitor concentration at which radioligand binding is 50% of control) were graphically determined from log-log& plots, and K, (apparent dissociation constant) values for U69,593-andnorbinaltorphimine were calculated usina the method of Chena and Prusoff (1973) 
, where [L] is the radioligand concentration and Ki is the equilibrium dissociation constant of the radioligand. Extracellular electrophysiology. Freshly dissected, transverse hippocampal slices (500 pm) from male Hartley guinea pigs (200-300 gm; Simonsen Laboratories, Gilroy, CA) were cut parallel to the visible alvear fibers. Slices were transferred to a submerged tissue recording chamber containing Krebs-bicarbonate buffer. Slices were continuously perfused at a flow rate of 1 ml/min and warmed to 34°C. Extracellular recording electrodes (l-2 pm tip) were filled with 3 M sodium chloride and placed in the granule cell layer of the dentate gyms. Population spike responses were evoked by stimulating the outer molecular layer of the dentate gyrus with a narrow (100 pm), concentric bipolar electrode (SNE-100, Kopf Instruments). Stimulation parameters consisted of single square waves of 25-400 PA of 0.3 msec duration. The amplitude of the population spike response (average maximal amplitude, 1.1 ? 0.1 mV; II = 30) was determined as shown in Figure 2B (inset).
Quantitation of drugefkts. The EC,, (the drug concentration at which half-maximal effect occurs) for U69,593 was graphically determined from dose-response curves. Drugs were dissolved in oxygenated Krebsbicarbonate buffer and applied to the tissue by bath superfusion. Responses were measured between 10 and 20 min after drug addition, at which time any change in the response was stable. The K, values for norbinaltorphimine were determined by the method of agonist dose ratios (Kosterlitz and Watt, 1968) . Briefly, K, = [A]I((DR'IDR) -l), where [A] is the norbinaltorphimine concentration, DR is the EC,,, and DR' is the EC,, in the presence of the antagonist. A norbinaltorphimine K, value was also obtained graphically from a Schild plot of the data (see Fig. 3B ), where the K, is the antilog of the x-intercept. Intracellular recording. Slices were obtained and treated as described for extracellular recording. Intracellular electrodes (50-100 MQ) were filled with 4 M potassium chloride or 4 M potassium methylsulfate. Synaptic responses were evoked as described for extracellular population spike responses. The slope of the excitatory postsynaptic potential (EPSP) was determined by measuring the rising phase of the EPSP as indicated by the asterisks in Figure 7 . Generally, the slope of the EPSP between 2 and 4 msec following the stimulus was used. The amplitude of the inhibitory postsynaptic potentials (IPSP) was determined by subtracting the potential at the peak of the late IPSP from the resting membrane potential. Sweeps were collected, digitized, and stored on an XT-class computer using the data acquisition program FAST-(Indec). For all comparisons described, statistical analyses were done using a paired t test; a values less than 0.05 were considered significant. A&terials. 3H-U69,593 and 3H-diprenorphine (48-65 Ci/mmol) were from Amersham:
(PLd 17), and [D~Pen2,'L-Pens]-enkephalin (DPLPE), from Peninsula; 2-amino-5-phosphonovaleric acid (APV), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), naloxone, and tetrodotoxin, from Sigma.
Results

K-Opioid binding site distribution
The distribution of K-opioid binding sites in the hippocampus was examined using either 3H-U69,593, a K,-selective radioligand (Zukin et al., 1988) or the nonselective opioid radioligand )H-diprenorphine in the presence of CL-and b-selective blocking ligands. Total 3H-diprenorphine binding in the absence of blockers showed opioid binding sites evenly distributed throughout the hippocampal slice with a moderate concentration in the perforant path terminal field (Fig. 1A) . The nonspecific 3H-diprenorphine binding remaining in the presence of excess naloxone (10 KM) was above film background ( Fig. 1B ) and represents binding at nonopioid sites. The addition of p-and b-receptor-selective blockers significantly reduced the binding of 3H-diprenorphine ( Fig. 1 C) . The residual naloxone-sensitive binding of 'H-diprenorphine (compare Fig. lB,C) showed the distribution of both K,-and x,-binding sites (Neck et al., 1990) . With the addition of unlabeled U69,593 to block K,-binding selectively, relatively little 3H-diprenorphine binding remained ( The distribution of K,-binding sites was also determined using 3H-U69,593 (Fig. 1E ). Total 3H-U69,593 binding was concentrated in the molecular layer of the dentate gyrus within the hippocampal formation and in the presubiculum region of temporal (ventral) slices (see Fig. 1 G for slice anatomy). This binding to K, was absent in the presence of excess naloxone (10
nonspecific binding was evenly distributed throughout the sections and was not significantly different from film background ( Fig. 10 . The pattern ofbinding seen using )H-U69,593 to label K,-sites strongly resembled the majority of the 3H-diprenorphine binding under conditions in which p-and &blockers were present (compare Fig. ICE ). Based on this comparison, as well as the sensitivity of these sites to the K,-SCkCtiVe ligand U69,593 (compare Fig. lC,D) , we concluded that the majority of the K-binding sites labeled by 3H-diprenorphine in the dentate molecular layer are of the K,-subtype. We concentrated our subsequent studies on the population of K,-binding sites in the dentate gyrus region.
K-Opioid eflects on the dentate population response Extracellular recording in the dentate granule cell layer was used to measure the population spike response evoked by stimulation of afferent perforant path fibers in the outer molecular layer (Fig. 28, inset). As reported previously in the rat dentate gyrus ) the stimulus-response relationship was biphasic, with supramaximal stimulus intensities resulting in decreasing population spike amplitudes (Fig. 24 . The addition of U69,593 (1 PM) resulted in a large inhibition of the population spike response without affecting the biphasic nature of the curve ( Fig. 2A) . The U69,593 inhibitory effect was dose dependent and reached a plateau at a concentration of 1 KM (Fig. 2B) . The reduction in spike amplitude caused by 1 PM U69,593 was 50 f 5% of control (mean + SEM; n = 5). Naloxone (300 nM) reversed the effects of U69,593, indicating the effect was mediated by an opioid receptor ( Fig. 2A ). Higher concentrations of U69,593 were not tested, as they have been shown to have naloxone-insensitive effects (Alzheimer et al., 1990) . To define the type of opioid receptor involved in mediating the observed effect, the potency and antagonist sensitivity of U69,593 were determined. Replotted as percentage of maximal U69,593 effect, the dose-response curve yields an EC,, value of 26 * 7 nM (n = 9; Fig. 3A ). Schild analysis was performed using the K-antagoniSt norbinaltorphimine (Takemori et al., 1988 ) a K,-SekctiVe ligand (Neck et al., 1990) . In each experiment, one concentration ofU69,593 (300 nM or 1 PM) was tested in the absence and presence of two concentrations of norbinaltorphimine (3 nM and 10 nM). The shift in agonist potency was used to calculate the apparent affinity of norbinaltorphimine (see Materials and Methods). The resulting Schild plot yields a norbinaltorphimine K, value of 0.2 nM (antilog of x-intercept), with a slope of 0.94 (indicative of interaction at a single receptor type; Fig. 3B ). The K, of norbinaltorphimine was also determined using the Kosterlitz and Watt (1968) method of agonist dose ratios (see Materials and Methods), resulting in a K, value of 0.26 f 0.04 nM (n = 15).
In vitro binding of K,-opioids
The pharmacological potency values obtained in the electrophysiologic assay for U69,593 and norbinaltorphimine were compared to their affinities for K,-binding sites determined under the same conditions. Guinea pig hippocampal membrane binding assays were done in Krebs-bicarbonate buffer, and competition curves for U69,593 and norbinaltorphimine against 3H-U69,593 (3 nM) were generated (Fig. 4) . The slopes obtained in log-logit plots were 1.03 -+ 0.10 and 0.98 + 0.11 for U69,593 and norbinaltorphimine, respectively (n = 4 for each), and the competition curves were of normal steepness based on the massaction kinetics at a single site (Fig. 4 ) both suggesting that competition was occurring at a single type of binding site at the concentration of radioligand used. Assuming that the ligand interactions were at a single site in the in vitro binding assay, the apparent K, for U69,593 was 2.6 + 1.5 nM and for norbinaltorphimine was 0.24 f 0.09 nM (n = 4 for each). The K, value for norbinaltorphimine calculated in the electrophysiologic assay (0.26 f 0.04 nM) agreed well with the result from the 3H-U69,593 membrane binding assay (0.24 f 0.09 nM), indicating that the same receptor type is being occupied in both assays by norbinaltorphimine. Although the potency of U69,593 in the electrophysiologic assay (26 + 7 nM) was approximately 1 O-fold lower than the binding affinity measured (2.6 f 1. Binding to non-p, non-& non-K, sites is remaining. E, 'H-U69,593 (3 nM) binding to K,-opioid binding sites. F, Nonspecific (nonopioid) 3H-U69,593 binding in the presence of excess naloxone (10 PM). G, Anatomical features referred to in the text are shown. lucidurn, stratum lucidum. The dentate gyms is composed of the molecular layer, dentate granule cell layer, and the hilus. For a more detailed description of hippocampal anatomy, see Bayer (1985) . Scale bar, 1 mm for A-F. A, A dose-response curve of the U69,593 was generated using the data from Figure 2b . Data points are the means + SEM of 5-l 2 independent experiments. The U69,593 concentration required to produce a halfmaximal effect (EC,,) was 26 k 7 nM (n = 9). For each determination of antagonist potency, a series of U69,593 doses was initially tested, then at the highest concentration of U69,593 tested (either 300 nM or 1 WM), and the effects of two concentrations of norbinaltorphimine (NBNZ) were sequentially determined. The K-antagonist norbinaltorphimine (3 nM or 10 nM) shifted the dose-response curve to the right in a dosedependent manner (NBNZ data are means + SEM of three to six independent experiments). B, A Schild plot of the agonist potency shift (DR'/DR) results in a calculated K, for norbinaltorphimine of 0.2 nM (slope of the line is 0.94).
EC,, values are a composite of affinity, efficacy, and response threshold and cannot be directly compared to the K, value (see Pratt and Taylor, 1990) . Opioid agonist affinity for K-reCeptOrS has been previously shown to be regulated by G-protein interactions (Tibet-i and Magnan, 1990) . We have found that the binding of 3H-U69,593 was decreased by the addition of GTPyS to the Krebs-bicarbonate buffer (IC,,) = 1 PM; data not shown). Thus, one contributing factor to the difference between the ag- The apparent equilibrium dissociation constants (K,) calculated by the Cheng-Frussoffequation were 2.6 + 1.5 for U69,593 and 0.24 k 0.09 for norbinaltorphimine (see Materials and Methods).
onist binding affinity and the pharmacologic potency was likely to be a consequence of the K,-receptor association with G-proteins under physiologic conditions. The concordance between the binding and physiologic data obtained using the antagonist norbinaltorphimine indicates that the site mediating the electrophysiological response to U69,593 is the K,-receptor.
Effects of other opioids on the dentate population response
In addition to U69,593, we tested the effects of other opioid agonists. The p-selective ligand PLO17 (0.3 or 1 PM) had no effect; the population spike amplitude in the presence of PLO 17 was 105 + 4% of control (n = 4; Fig. 5B ). The &selective ligand DPLPE (0.3 or 1 FM) also had no effect on the maximal population spike amplitude; the response was 102 f 5% of control (n = 4; Fig. 5D ). However, DPLPE caused a shift in the biphasic nature of the stimulus-response curve that was partially reversed by naloxone (300 nM). Previous work has shown that d-receptor activation caused a similar shift in the biphasic stimulus-response curve in the rat dentate gyrus . Dynorphin B (3 PM) application resulted in a statistically significant decrease in the maximal population spike amplitude to 77 + 6% of control (n = 4; p < 0.05), without changing the biphasic nature of the stimulus-response curve (Fig. 5A ). Both dynorphin B and U69,593 effects were reversed by norbinaltorphimine (100 nM; Fig. SA,C') . The results suggest that dynorphin B similarly activates K,-receptors. Intensity (IA) Stimulus Intensity @A) Figure 5 . As with U69,593, dynorphin B decreases the amplitude of the dentate population spike response, whereas p-(PLO1 7) and d-(DPLPE) selective opioid agonists do not. Results from representative experiments show the amplitude of the population spike evoked by stimulation in the molecular layer at different stimulus intensities (control). A, The addition of dynorphin B (Dyn B; 3 PM) to the superfusion buffer decreased the amplitude of the population spike. Coapplication of norbinaltorphimine (NBNI; 100 nM) reversed the effect of dynorphin B. B, The addition of the r-selective agonist PLO17 (300 nM) had no effect on the amplitude of the evoked response. C, The addition of U69.593 (300 nM) decreased the amplitude ofthe population spike. Coapplication of norbinaltorphimine (NBNI; 100 nM) reversed the effect of U69,593. D, The addition of the &selective agonist DPLPE (300 nM) had no effect on the amplitude of the evoked response, but did shift the biphasic shape of the response curve. Coapplication of naloxone (Nul; 300 IIM) partially reversed this Sopioid effect. observed using extracellular recording. Granule cell recordings show that stimulation of afferent perlorant path fibers in the outer molecular layer evoked an EPSP followed by a complex IPSP response (Fig. 6A,B) . The magnitude of the evoked IPSPs directly corresponded to the amplitude of the stimulus at all intensities tested (Fig. 6A) . At a low stimulus intensity (25 PA), an EPSP was evoked, but an action potential was not initiated. As expected, a higher stimulus intensity (50 PA) induced an EPSP response of sufficient size to elicit an action potential (Fig. 6B) . Interestingly, at the highest stimulus intensity (200 PA), the action potential was suppressed by the overlying IPSP response (Fig. 6B) . This biphasic response for action potential generation was observed in 7 of 11 dentate granule cells and is consistant with a mechanism involving the direct activation of inhibitory circuits in the dentate gyrus by stimulation in the molecular layer.
K,-Receptor activation could act to inhibit the population spike amplitude by either a direct effect on the granule cells, a reduction in excitatory synaptic input, or an increase in the inhibitory synaptic input. Application of U69,593 (300 nM) had no effect on either granule cell membrane potential or membrane resistance (Table 1 ). The EPSPs evoked by afferent stimulation were reduced by U69,593, and the action potential induction was blocked (Fig. 7A) . The slope of the rising phase of the EPSP was significantly inhibited by U69,593 to 46% of control (Table l) , and the effects of U69,593 were reversed by norbinaltorphimine (100 nM; Fig. 7A ). The effects of U69,593 on IPSPs were examined under conditions in which EPSPs were abolished (10 KM CNQX and 25 FM APV). In the absence of excitatory synaptic transmission, stimulation in the outer molecular layer will still evoke an IPSP caused by direct activation of the dendrites of GABAergic neurons (Fig. 7B) . U69,593 (300 nM) did not significantly affect the IPSP amplitudes under these conditions (Table 1, Fig. 7B ). These results indicate that the principal effect Of K,-TeCeptOr activation was to inhibit the excitatory amino acid release from the perforant path terminals in the molecular layer of the dentate gyrus.
Discussion
Our study provides a clear demonstration of the naloxone-sensitive effects of K,-opioid ligands in the dentate gyrus region. Dentate granule cell excitability in response to afferent stimulation was inhibited in the presence of either U69,593, a K,-selective opioid agonist, or dynorphin B, an endogenous opioid peptide. The inhibitory effect of U69,593 on granule cell excitability in extracellular electrophysiologic assays was found to be mediated by K,-opioid receptor activation. The ability of U69,593 to activate the K,-Opioid receptor and elicit physiologic effects indicates that this subtype of K-binding site is a functionally coupled opioid receptor in the hippocampus. Intracellular recording of dentate granule cells was done to determine the effects ofU69,593 (300 no). Resting membrane potential and input resistance were measured in the presence of low-Ca+, high-Mg+ buffer to block synaptic activity. EPSP slope was measured in normal Krebs-bicarbonate buffer as shown in Figure 7A . IPSP potentials were obtained in the absence of EPSPs with the addition of CNQX (10 MM) and APV (25 PM) to the buffer. The amplitudes of the IPSPs were determined by subtracting the potential at the peak of the late IPSP from the resting membrane potential. *p < 0.03 by paired t test. B Figure 7 . U69,593 reduced the amplitude of the excitatory synaptic potentials and blocked action potential induction in dentate granule cells. Synaptic potentials in two representative granule cells were evoked by stimulation of the perforant path in the outer molecular layer. A, As evident at a fast oscilloscope speed, EPSPs and action potentials were elicited by perforant path stimulation (50 PA) prior to drug addition (Control), but not in the presence of 300 nM U69,593. The inhibitory effect of U69,593 was reversed by 100 nM norbinaltorphimine (U69.593 + NBNI). Asterisks indicate the linear region of the EPSP where the slope of the EPSP was determined. V, = -70 mV. Calibration: 10 mV, 2 msec. B, As evident at a slower oscilloscope speed, IPSPs evoked by direct stimulation of GABA-containing neurons were not influenced by 300 nM U69,593 in the absence of EPSPs, which were blocked by 25 PM D-APV and 10 NM CNQX. The slight difference evident in the amplitudes of the late IPSPs of the two traces shown was inconsistent from cell to cell and not statistically significant (see Table 1 ). Stimulation intensity was 300 PA. V,,, = -59 mV. Calibration: 5 mV, 100 msec.
Application of dynorphin B, an endogenous opioid peptide present in the granule cells in the guinea pig dentate gyrus (McLean et al., 1987) , resulted in inhibition of the population spike amplitude to a lessor extent than that found with U69,593. We attributed this apparent difference in potency either to enzymatic degradation of the peptide or to a reduced ability of dynorphin B to diffuse through the tissue (Herman et al., 1980; Ho et al., 1980) . The dynorphin B effect was likely to be mediated by K,-opioid receptor, based on the similarity to the U69,593 effect and on its sensitivity to norbinaltorphimine, a K,-S&&W antagonist. Opioid agonists selective for M-and &re-ceptors were tested and found to have no effect on the dentate population spike amplitude. The results suggest that a physiological role of the endogenous dynorphins present in the granule cells may be to activate K,-reCeptOrS in the dentate gyrus to regulate excitability of this region.
Several potential mechanisms could underly the observed reduction in the amplitude of the extracellularly recorded population spike response. The lack of effect of U69,593 on resting membrane potential or input resistance argues against a direct inhibitory action of K,-Opioids on the granule cells themselves. The possibility of a direct antagonistic effect of U69,593 on glutamate receptor activation is not consistent with the ability of naloxone and norbinaltorphimine to block the actions of U69,593. The lack of effect of U69,593 on IPSP amplitudes measured intracellularly in granule cells indicates that GABAergic input was unaffected. A fourth possibility involved a decrease in excitatory transmitter release at presynaptic terminals. U69,593 reduced the slope of the rising phase and maximal amplitude of the EPSP, which results in a failure to generate an action potential. The excitatory transmitter was likely to be glutamate because the EPSPs were completely blocked by APV and CNQX. Therefore, we conclude that K,-reCeptOrS in the molecular layer are likely to be located presynaptically on perforant path terminals and act to inhibit excitatory transmitter release. These results are consistent with an initial report showing that micromolar concentrations of a nonselective opioid inhibit EPSPs in the rat dentate gyrus (Moore et al., 1988) , and (McFadzean et al., 1987) . Also, using a biochemical measure, Terrian and coworkers (Gannon and Terrian, 1991) have also found that K-opioids inhibit glutamate release from hippocampal synaptosomes. The inhibition of transmitter release by opioid receptor activation has been previously described at other sites in the nervous system (Illes, 1989) . However, the reduction in cellular excitability caused by K-receptor activation is different from the effects previously described for opioids in the hippocampus . The principal effect of p-or s-receptor activation is a disinhibition caused by the inhibition of GABA release from inhibitory intemeurons (Zieglgansberger et al., 1979) . Whether the inhibition of transmitter release caused by K,-reCeptOrS results from a direct effect on calcium entry into the nerve terminal or indirectly by an increase in potassium conductance is not yet known, but previous studies have shown that K-reCeptOrS on other neurons can directly regulate calcium conductances Macdonald, 1984, 1985) .
We have used opioid radioligands in an attempt to compare the localization of KI-and K,-binding sites to identify likely sites of action for endogenous dynorphins in the hippocampal formation. We have found that the K,-subtype of binding sites are localized in the dentate molecular layer, but not found in the stratum lucidum (Wagner et al., 1991) . Similarly, Sharif et al. (1988) found that 3H-dynorphin A( l-8), which has a much lower affinity for the K2-than the K,-Subtype (Neck et al., 1990) , also labeled K-SitCS only in the molecular layer of the dentate gyrus. The lack of K,-SiteS in the stratum lucidum is significant because this region has a dense concentration of fibers containing prodynorphin-derived opioids and was predicted to be a likely site of endogenous dynorphin action (McGinty et al., 1983; McLean et al., 1987) . The K-binding sites in the stratum lucidum visualized by less selective K-radioligands (McLean et al., 1987; Zukin et al., 1988) are likely to correspond to the K,-subtype of opioid receptor. Better resolution of the K,-binding site distribution requires a more selective radioligand.
In a previous report, we used an in vitro slice binding method to demonstrate the release of endogenous dynorphins in response to electrical stimulation of fiber tracts in the guinea pig hippocampus. The results of that study indicate that dynorphins can be released by physiologically appropriate stimuli from granule cells to occupy K,-SiteS (Wagner et al., 1991) . As the K,-binding sites were localized to the molecular layer of the dentate gyrus as described previously, the nearest sites of dynorphin release from the granule cells would be from the axon collaterals in the hilus of the dentate gyrus (Claibome et al., 1986) . A neurohormonal mechanism of neuropeptide action has been previously described for leutinizing hormone-releasing hormone (Jan and Jan, 1982) and previously proposed for endogenous opioids based on the mismatch between the localization of opioid peptides and their receptors (McLean et al., 1987) . Alternatively, the release of dynorphin from granule cell dendrites in the molecular layer is possible, but no anatomical evidence supporting this is available. The specific site of endogenous dynorphin release remains to be determined.
Based on our results, we propose that endogenous dynorphins can be released from dentate granule cells to act at K,-reCeptOrS in the molecular layer of the dentate gyrus, thereby inhibiting excitatory input into the dentate granule cells from the perforant path. The evidence supporting this hypothesis is substantial. Receptor autoradiography showed that the K,-SiteS were concentrated in the molecular layer of the dentate gyrus (Wagner et al., 199 1) . Immunocytochemical localization of prodynorphin-derived peptides in the guinea pig hippocampus has shown them to be present in the dentate gyrus region. Dynorphin B was primarily located in the mossy fiber projections of granule cells, but also found in occasional granule cell processes in the molecular layer (McLean et al., 1987) . Dynorphins can be released in response to stimulation of the dentate gyrus and are able to occupy K,-binding sites in the molecular layer of the dentate gyrus (Wagner et al., 199 1) . Also, in the present study, we showed that K,-receptor activation decreases excitatory synaptic transmission from the perforant path to the dentate granule cells in the dentate gyrus. This proposed mechanism of endogenous dynorphin action must be directly verified by showing an effect of released peptide on EPSPs recorded in the dentate granule cells.
An action of dynorphin to reduce excitatory synaptic transmission into the dentate gyrus would be an example of feedback inhibition in which the postsynaptic granule cell is the source of an inhibitory transmitter regulating transmitter release from perforant path terminals. A similar role for dynorphin has been demonstrated in the posterior pituitary, where dynorphin is coreleased with vasopressin and acts to inhibit the release of oxytocin from neighboring neurosecretory terminals (Bondy et al., 1988) . The physiologic significance of dynorphin action would be a role in regulating the hyperexcitability of the dentate gyrus. Consistent with this suggestion, dynorphin levels in the dentate gyrus are changed in human epilepsy (Houser et al., 1990) and in experimental animal seizure models (Kanamatsu et al., 1986; Gall, 1988) . Regulation of the excitable state of the dentate gyrus by dynorphin may also have a physiological role in long-term potentiation (LTP). A feedback relationship between postsynaptic cell and presynaptic terminal has previously been proposed to be involved in the maintenance of LTP, where the retrograde transmitter is thought to have a facilitatory effect on transmitter release (Bliss et al., 1986) . By acting at the dentate granule cellperforant path synapse, the endogenous dynorphin system would potentially modulate the function of many hippocampal processes, as the dentate gyrus is the gateway through which the majority of the incoming information from higher cortices must pass when entering the hippocampal formation.
